Sign in

Alex Parrish

Senior Equity Analyst at Barrington Research

Alex Paris is a Senior Equity Analyst at Barrington Research, specializing in education services and related sectors. He actively covers companies such as Stride Inc., regularly delivering buy ratings and maintaining high price targets that have outperformed market consensus, including a recent target of $185 with a forecasted upside of over 20%. Paris has built his reputation through consistent, data-driven investment calls supported by rigorous financial analysis, and his performance is closely tracked on platforms like TipRanks and Benzinga. With over a decade of industry experience, he has covered multiple leading education and technology firms, and holds professional credentials, including active FINRA registration and relevant securities licenses.

Alex Parrish's questions to Stride (LRN) leadership

Question · Q1 2026

Alex Parrish sought clarification on the timing of the 10,000-15,000 enrollment shortfall (before or after the count date), the implications for Q2 revenue guidance given the 11.3% fall term enrollment growth, the expected in-year enrollment trajectory, and the revised outlook for revenue per enrollment.

Answer

CEO James Rhyu clarified that the vast majority of the 10,000-15,000 enrollment impact occurred in the first fiscal quarter (through September 30th). He explained that Q2 revenue growth appears lower due to a tougher year-over-year comparison against rising enrollments in the prior year, and that Stride does not anticipate in-year enrollment growth from the beginning to the end of the current fiscal year. CFO Donna Blackman added that while the funding environment remains positive, state mix and the absence of the prior year's in-year enrollment growth adjustments lead to a revised flat outlook for revenue per enrollment.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts